ALS Stem Cell Trial Gets FDA Go Ahead
The US Food and Drug Administration (FDA) said the first clinical trial to test a new stem cell treatment for the fatal neurodegenerative disease ALS (amyotrophic lateral sclerosis) this month (ALS) can go ahead.
[Read the full article here]Related News:
FDA Approves Stem Cell Trial For ALS Treatment
Clinic to participate in stem-cell trial
FDA approves Neuralstem's IND for commencing a stem cell trial to treat Amyotrophic Lateral Sclerosis